Company / Accounts Receivable
Warby Parker Inc. Accounts Receivable History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$3.3M
FY2025
5-year range
$992.0K / $3.3M
FY2021-FY2025
Trend
+68.6%
vs FY2024
Sector context
#137 of 138
Health Care
What the data says
Among 138 Health Care companies, Warby Parker Inc. is in the bottom 1% for accounts receivable. Accounts Receivable has increased for 5 consecutive years, from $601,000 in FY2020 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +40.5%.
Improved from $2M to $3M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +31.8%
- 5-Year CAGR
- +40.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 138This company $3.3M Sector average $1.3B
▼
-99.8% below sector average
Key checks
Key Insights
- Warby Parker Inc.'s accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +40.5%, indicating consistent growth.
- In FY2025, accounts receivable increased 68.6% year-over-year.
- Ranks #137 out of 138 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.3M | +68.6% |
| FY2024 | $1.9M | +9.5% |
| FY2023 | $1.8M | +24.0% |
| FY2022 | $1.4M | +44.7% |
| FY2021 | $992.0K | +65.1% |
| FY2020 | $601.0K | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026